Open

Leukemia Treatment Study

In this study, we want to see if a new drug called Ziftomenib can help treat or cure Leukemia. We want to find out if it is safe and if it works well for people with this disease.

Age & Gender

18 years ~ 99 years
Male, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

This study involves blood work and vital signs, questionnaires, and a physical exam. The study also involves an ECG, bone marrow biopsies, bloodwork and questionnaires.

Incentives

Information provided upon request

In-person visits:
15+

Total length of participation:
24

Looking for Specific Volunteers

Able to participate:

You are diagnosed with Leukemia
You have a functioning kidney, lover, cardiac organ

Not eligible if:

Any other type of cancer
You have Leukemia with central nervous system involvement
You have an active uncontrolled infection

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Clinical Research
cancerclinicaltrials@med.unc.edu
(919) 966-4432

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Joshua Zeidner
Lineberger Comprehensive Cancer Center

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Leukemia)

IRB Number

25-1479

ClinicalTrials.gov

NCT05735184

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.